Attached files
| file | filename |
|---|---|
| EX-4.9 - EXHIBIT 4.9 - AIkido Pharma Inc. | s102876_ex4-9.htm |
| EX-31.1 - EXHIBIT 31-1 - AIkido Pharma Inc. | s102876_ex31-1.htm |
| EX-32.1 - EXHIBIT 32-1 - AIkido Pharma Inc. | s102876_ex32-1.htm |
| EX-31.2 - EXHIBIT 31-2 - AIkido Pharma Inc. | s102876_ex31-2.htm |
| EX-21.1 - EXHIBIT 21.1 - AIkido Pharma Inc. | s102876_ex21-1.htm |
| EX-32.2 - EXHIBIT 32-2 - AIkido Pharma Inc. | s102876_ex32-2.htm |
| EX-10.23 - EXHIBIT 10-23 - AIkido Pharma Inc. | s102876_ex10-23.htm |
| EX-10.24 - EXHIBIT 10-24 - AIkido Pharma Inc. | s102876_ex10-24.htm |
| EX-10.26 - EXHIBIT 10-26 - AIkido Pharma Inc. | s102876_ex10-26.htm |
| 10-K - FORM 10-K - AIkido Pharma Inc. | s102876_10k.htm |
Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in the Registration Statements of Spherix Incorporated and Subsidiaries (the “Company”) on Form S-3 (File No. 333-198498), Form S-3 (File No. 333-195346), Form S-8 (File No. 333-197429), Form S-8 (File No. 333-187811), Form S-8 (File No. 333-185524) and Form S-3 (File No. 333-193729) of our report, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, dated March 29, 2016, with respect to our audits of the consolidated financial statements of the Company as of December 31, 2015 and 2014 and for the years then ended, which report is included in this Annual Report on Form 10-K of Spherix Incorporated and Subsidiaries for the year ended December 31, 2015.
| /s/ Marcum LLP |
| Marcum LLP |
| New York, NY |
| March 29, 2016 |